Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by stockhunter1on Jul 03, 2019 10:13pm

99 Views

Post# 29885375

Longs will be rewarded !!

The data from this first release[ Chicago Trial] is huge and will get the due attention...it is only a matter of time now! Longs sit back and know the fruit is at hand.

-https://chicago.suntimes.com/2019/7/3/20680122/implanted-cell-pouch-could-help-type-1-diabetics-researchers-say

Bullboard Posts

Full Circle Lithium goes global with its battery fire-fighter